5//SEC Filing
Abd El-Shafy Mohammed 5
Accession 0001014858-04-000013
CIK 0001043873other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 7:03 PM ET
Size
10.2 KB
Accession
0001014858-04-000013
Insider Transaction Report
Form 5
Abd El-Shafy Mohammed
VP, Pharmaceutical Development
Transactions
- Award
Stock Option (Right to Buy)
2002-05-21+150,000→ 150,000 totalExercise: $3.02Exp: 2010-05-20→ Common Stock (150,000 underlying) - Award
Stock Option (Right to Buy)
2004-02-24+50,000→ 50,000 totalExercise: $1.65From: 2004-02-24Exp: 2009-02-23→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2003-03-28+50,000→ 50,000 totalExercise: $1.51From: 2003-03-28Exp: 2008-03-27→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The Options vest in three annual installments: 50,000 options become exercisable on November 15, 2002; 50,000 options become exercisable on May 15, 2003; and 50,000 options become exercisable on May 15, 2004.
Documents
Issuer
NOVADEL PHARMA INC
CIK 0001043873
Entity typeother
Related Parties
1- filerCIK 0001303695
Filing Metadata
- Form type
- 5
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 7:03 PM ET
- Size
- 10.2 KB